Evotec (ETR:EVT) Share Price Crosses Below 50 Day Moving Average – Here’s What Happened

Evotec SE (ETR:EVT)’s stock price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of €3.88 and traded as low as €3.15. Evotec shares last traded at €3.15, with a volume of 823,198 shares changing hands.

Evotec Stock Down 1.0%

The company has a quick ratio of 2.97, a current ratio of 2.33 and a debt-to-equity ratio of 71.50. The stock’s 50-day simple moving average is €3.85 and its 200 day simple moving average is €4.60. The firm has a market cap of $607.47 million, a P/E ratio of -3.54, a PEG ratio of 0.98 and a beta of 1.26.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer, as well as a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic.